Studies

CellWell record HH-471381

Serum protein induced by vitamin K absence or antagonist-II predicts aggressive tumor biology in alpha-fetoprotein-normal hepatocellular carcinoma

Zaigham Abbas; Darayus P Gazder; Zeeshan Hyder; Muhammad Ali Qadeer; Minaam Abbas

2026

In plain language

In 113 patients with liver cancer and normal AFP levels, PIVKA-II above 400 mAU/mL was strongly associated with aggressive tumors that exceeded transplant size limits or involved portal vein clots.

Evidence
Emerging
Design
Primary research (design unspecified)

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-471381

Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.